ClinicalTrials.Veeva

Menu

Development of a New Instrument to Evaluate Gait Characteristics of Individuals With Duchenne Muscular Dystrophy

H

Hacettepe University

Status

Completed

Conditions

Gait Disorders in Children
Gait Disorders, Neurologic
Duchenne Muscular Dystrophy

Treatments

Other: Duchenne Muscular Dystrophy Gait Assessment Scale

Study type

Interventional

Funder types

Other

Identifiers

NCT05244395
GO 20/1058

Details and patient eligibility

About

The aim of this study was to develop a gait assessment instrument for Duchenne Muscular Dystrophy patients (DMD-GAS), and investigate its validity and reliability.The scale was developed considering the expert opinions which included 10 physiotherapists who had experience in the management of patients with DMD over the 2-round Delphi method, and the Content Validity Index (CVI) was calculated. The final version of the DMD-GAS that was agreed upon the experts consisted of 10 items, and each item scored between 0 and 2. The intra-rater reliability was established by the video analysis of children with a 1-month interval and inter-rater reliability was determined by the scores of 3 physiotherapists. The criterion validity was determined by investigating the relationship between the total score of the DMD-GAS and Motor Function Measure (MFM), 6 Minute Walk Test (6MWT), and the data obtained from GAITRite system.

Enrollment

56 patients

Sex

Male

Ages

5 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Being diagnosed with DMD
  2. Be between Levels I-V according to Brooke Lower Limb Extremity Functional Classification
  3. Being between the ages of 5-18
  4. Agreeing to participate in the research voluntarily

Exclusion criteria

  1. Insufficient cooperation with the physiotherapist,
  2. Have had any injury and/or surgery of the lower extremities in the last 6 months,
  3. Having neurological problems in addition to DMD. -

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

56 participants in 1 patient group

Duchenne Muscular Dystrophy Gait Assessment Scale
Experimental group
Description:
The DMD-GAS was developed using the two-round Delphi method. After a detailed literature review, the items of scale were compiled. The DMD-GAS was designed to consist of 10 items and each item scored as 0,1,2. The DMD-GAS was presented to the expert group (10 physical therapists), who had experience in the management of patients with DMD. According to the scale items, it is classified as 2: no compensation, 1: minimal compensation, and 0: excessive compensation for the relevant body part.
Treatment:
Other: Duchenne Muscular Dystrophy Gait Assessment Scale

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems